Rhythm Pharmaceuticals, Inc. (RYTM)
84.33
-0.29
(-0.34%)
USD |
NASDAQ |
Mar 26, 10:04
Rhythm Pharmaceuticals EPS Diluted (Quarterly) : -0.7302 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| MannKind Corp. | -0.0519 |
| EyePoint Plc | -0.8143 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.50M |
| Revenue (Quarterly) | 57.25M |
| Total Expenses (Quarterly) | 104.76M |
| Enterprise Value | 5.632B |
| Gross Profit Margin (Quarterly) | 91.61% |
| Profit Margin (Quarterly) | -82.97% |
| Earnings Yield | -3.69% |
| Normalized Earnings Yield | -3.675 |